Changing pattern of imported cutaneous leishmaniasis in the Netherlands

Clinical and Experimental Dermatology

Volumn 30, Issue 1, 2005, Pages 1-5

  Zeegelaar, J E ^a   Steketee, W H ^a   Van Thiel, P P A M ^a   Wetsteyn, J C F M ^a   Kager, P A ^a   Faber, W R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; ITRACONAZOLE; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; BELIZE; BOLIVIA; CHILD; CRYOSURGERY; CRYOTHERAPY; DIAGNOSTIC PROCEDURE; FEMALE; FRENCH GUIANA; GIEMSA STAIN; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NETHERLANDS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SKIN BIOPSY; SKIN LEISHMANIASIS; SURINAME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMONY; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; ITRACONAZOLE; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; NETHERLANDS; PENTAMIDINE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 13244252330     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01677.x     Document Type: Article

References (24)

1. Dedet JP, Pratlong F, Lanotte G, Ravel C. Cutaneous leishmaniasis. The parasite. Clin Dermatol 1999; 17: 261-8.
2. Salman SM, Rubeiz NG, Kibbi A-G. Cutaneous leishmaniasis. clinical features and diagnosis. Clin Dermatol 1999; 17: 291-6.
3. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-72.
4. Killick-Kendrick R. The biology and control of phlebotomine sand flies. Clin Dermatol 1999; 17: 279-89.
5. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol 1996; 14: 417-23.
6. Choi CM, Lerner EA. Leishmaniasis as an emerging infection. J Invest Dermatol Symp Proc 2001; 6: 175-82.
7. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-9.
8. Morris RV, Shoemaker CB, David JR et al. Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol 2001; 167: 5226-30.
9. Koff AB, Rosen T. Treatment of cutaneous leishmaniasis. J Am Acad Dermatol 1994; 31: 696-708.
10. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703.
11. Blum J, Desjeux P, Schwartz E et al. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004; 53: 158-66.
12. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296-306.
13. Kager PA. Leishmania species (Leishmaniasis). In: Yu VL, Weber R, Raoult D, eds. Antimicrobial Therapy and Vaccines. New York: Apple Trees Productions, 2002: 1555-80.
14. Faber WR, Becht M, van Ginkel CJ et al. Cutaneous leishmaniasis in 49 patients in the Netherlands. Ned Tijdschr Geneeskd 1991; 135: 229-33 (in Dutch).
15. Faber WR, Oskam L, van Gool T et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003; 49: 70-4.
16. The leishmaniases. Report WHO Expert Committee WHO Tech Rep Series 1984; 701: 99-109.
17. Oliveira-Neto MP, Schubach A, Mattos M et al. A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years). Am J Trop Med Hyg 1997; 57: 651-5.
18. Gurei MS, Tatli N, Ozbilge H et al. Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 2000; 30: 169-76.
19. Tallab TM, Bahamdam KA, Mirdad S et al. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol 1996; 35: 594-7.
20. Lai A, Fat EJ, Vrede MA, Soetosenojo RM, Lai A, Fat RF. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 2002; 41: 796-800.
21. Soto-Mancipe J, Grogl M, Berman JD. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 1993; 16: 417-25.
22. Nacher M, Carme B, Sainte Marie D et al. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guyana. Ann Trop Med Parasitol 2001; 95: 331-6.
23. Momeni AZ, Jalayer T, Emamjomeh M et al. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study. Arch Dermatol 1996; 32: 784-6.
24. Alrajhi AA, Ibrahim EA, De EB et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Medical 2002, 346, 891-5.